Trial Profile
A Safety and Efficacy Study of Doxil and Taxotere +/- Herceptin in Advanced Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Docetaxel; Doxorubicin liposomal
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Sep 2005 New trial record.